• Chronic renal failure with secondary hyperparathyroidism

• Bone pain, pruritus, weakness, insomnia

• Osteoporosis

• Sexual dysfunction

• Cognitive impairment

• Before/after renal transplantation

Kaohsiung Chang Gung Memorial Hospital, led by Prof. Feng-Fu Chou, built the "From Black and White to Color" endocrine surgical team for renal failure patients with SHPT. The team is committed to innovative medical technology, academic publications, surgical technique inheritance, and elevating standards. Standardized tissue specimen cryopreservation (4°C → RPMI freezing solution → overnight → liquid nitrogen). Innovative discoveries: (1) Post-op muscle strength increase 40% (Arch Surg 1999); (2) World-first finding of increased muscle force, unchanged motor nerve conduction velocity, increased CMAP after PTX (Acta Neurol Scand 2002); (3) Reduced calcium-phosphorus product improves pruritus post-op (J Am Coll Surg 2000); (4) Surgery improves anemia (Blood Purif 2003); (5) World-first paper on sexual function improvement (J Am Coll Surg 2001); (6) World-first paper on parathyroidectomy and sperm motility (J Am Coll Surg 2003); (7) Post-op sleep quality improvement (Surgery 2005); (8) World-first paper on cognitive improvement (Surgery 2008); (9) Major BMD improvement led to T-score <-2.5 as surgical indication (Arch Surg 2001); (10) Post-op hypoparathyroidism has no adverse effects (World J Surg 2010); (11) PTX followed by kidney transplant improves BMD (Transplantation 2008). Innovative technique: First subcutaneous forearm autotransplantation, replacing traditional intramuscular technique (Surgery 1998). Research tracked by BioMedLib; multiple papers internationally cited.

• First subcutaneous forearm parathyroid autotransplant

• World-first papers on sexual function, sperm motility, cognition

• T-score <-2.5 as surgical indication

• Multiple BioMedLib-tracked publications

• 40% post-op muscle strength gain

• Expanded indications (from bone pain to osteoporosis)

• Accumulated SHPT surgical experience

• Kaohsiung CGMH renal failure dialysis (HD 908, CAPD 324)

• Multiple tissue cryopreservation studies

• Multiple innovative indication studies

• Improved parathyroidectomy quality

• Promoted new parathyroidectomy indications

• 40% post-op muscle strength gain

• Unchanged motor nerve conduction, increased CMAP

• Pruritus and anemia improvement

• Sexual function improvement

• Sleep quality improvement

• Post-op cognitive improvement

• Standardized tissue specimen cryopreservation

• RPMI freezing solution preparation

• Pre-op evaluation: Ca, P, Alk-P, Aluminum, iPTH, BMD, MMSE, CDR, Thallium heart scan

• Post-op hypoparathyroidism shows no adverse effects

• Cross-team integrated care

• Strict follow-up

• Significant patient satisfaction increase

• Male patients regain sexual function

• Family appreciation for cognitive recovery

• Sleep quality improvement

• Continuous international citation recognition

• BioMedLib continuous tracking recognition

• Arch Surg 1999/2001 publications

• Acta Neurol Scand 2002 world-first paper

• J Am Coll Surg 2000/2001/2003 world-firsts

• Surgery 1998/2005/2008 surgical innovation

• Transplantation 2008 PTX with renal transplant

• World J Surg 2010 hypoparathyroidism no harm

• Domestic/international parathyroidectomy exemplar

• Subcutaneous forearm autotransplant widely adopted

• Promotes new SHPT indications (BMD, sexual function, cognition)

• Improves post-op QoL of renal failure patients

• Trains domestic/intl endocrine surgery specialists

• Promotes surgical techniques internationally